These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 34986364)

  • 1. Assessing the effect of blood type on death and a novel scoring system to assess clinical course in patients with COVID-19.
    Thomas KE; Karamanis A; Dauchy E; Chapple AG; Loch MM
    Am J Med Sci; 2022 Jul; 364(1):7-15. PubMed ID: 34986364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.
    Hesni E; Sayad B; Khosravi Shadmani F; Najafi F; Khodarahmi R; Rahimi Z; Bozorgomid A; Sayad N
    BMC Infect Dis; 2022 Mar; 22(1):319. PubMed ID: 35361161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
    Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
    JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Do Presenting Symptoms and Outcomes Differ by Race/Ethnicity Among Hospitalized Patients With Coronavirus Disease 2019 Infection? Experience in Massachusetts.
    McCarty TR; Hathorn KE; Redd WD; Rodriguez NJ; Zhou JC; Bazarbashi AN; Njie C; Wong D; Trinh QD; Shen L; Stone VE; Chan WW
    Clin Infect Dis; 2021 Dec; 73(11):e4131-e4138. PubMed ID: 32827436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
    Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K
    Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America.
    Yang JY; Parkins MD; Canakis A; Aroniadis OC; Yadav D; Dixon RE; Elmunzer BJ; Forbes N;
    JAMA Netw Open; 2021 Jan; 4(1):e2035699. PubMed ID: 33507259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body Mass Index, Multi-Morbidity, and COVID-19 Risk Factors as Predictors of Severe COVID-19 Outcomes.
    Nanda S; Chacin Suarez AS; Toussaint L; Vincent A; Fischer KM; Hurt R; Schroeder DR; Medina Inojosa JR; O'Horo JC; DeJesus RS; Abu Lebdeh HS; Mundi MS; Iftikhar S; Croghan IT
    J Prim Care Community Health; 2021; 12():21501327211018559. PubMed ID: 34024181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial Disparities in COVID-19 Testing and Outcomes : Retrospective Cohort Study in an Integrated Health System.
    Escobar GJ; Adams AS; Liu VX; Soltesz L; Chen YI; Parodi SM; Ray GT; Myers LC; Ramaprasad CM; Dlott R; Lee C
    Ann Intern Med; 2021 Jun; 174(6):786-793. PubMed ID: 33556278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood type and outcomes in patients with COVID-19.
    Latz CA; DeCarlo C; Boitano L; Png CYM; Patell R; Conrad MF; Eagleton M; Dua A
    Ann Hematol; 2020 Sep; 99(9):2113-2118. PubMed ID: 32656591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.
    Meng Y; Lu W; Guo E; Liu J; Yang B; Wu P; Lin S; Peng T; Fu Y; Li F; Wang Z; Li Y; Xiao R; Liu C; Huang Y; Lu F; Wu X; You L; Ma D; Sun C; Wu P; Chen G
    J Hematol Oncol; 2020 Jun; 13(1):75. PubMed ID: 32522278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Factors Associated With Coronavirus Disease 2019 Infection, Hospitalization, and Mortality Across Race and Ethnicity.
    Dai CL; Kornilov SA; Roper RT; Cohen-Cline H; Jade K; Smith B; Heath JR; Diaz G; Goldman JD; Magis AT; Hadlock JJ
    Clin Infect Dis; 2021 Dec; 73(12):2193-2204. PubMed ID: 33608710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis.
    Salter A; Fox RJ; Newsome SD; Halper J; Li DKB; Kanellis P; Costello K; Bebo B; Rammohan K; Cutter GR; Cross AH
    JAMA Neurol; 2021 Jun; 78(6):699-708. PubMed ID: 33739362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
    Simpson-Yap S; De Brouwer E; Kalincik T; Rijke N; Hillert JA; Walton C; Edan G; Moreau Y; Spelman T; Geys L; Parciak T; Gautrais C; Lazovski N; Pirmani A; Ardeshirdavanai A; Forsberg L; Glaser A; McBurney R; Schmidt H; Bergmann AB; Braune S; Stahmann A; Middleton R; Salter A; Fox RJ; van der Walt A; Butzkueven H; Alroughani R; Ozakbas S; Rojas JI; van der Mei I; Nag N; Ivanov R; Sciascia do Olival G; Dias AE; Magyari M; Brum D; Mendes MF; Alonso RN; Nicholas RS; Bauer J; Chertcoff AS; Zabalza A; Arrambide G; Fidao A; Comi G; Peeters L
    Neurology; 2021 Nov; 97(19):e1870-e1885. PubMed ID: 34610987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian framework for estimating the risk ratio of hospitalization for people with comorbidity infected by SARS-CoV-2 virus.
    Gao X; Dong Q
    J Am Med Inform Assoc; 2021 Mar; 28(3):472-476. PubMed ID: 32986795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Nursing Home COVID-19 Patients by Initial Symptoms and Comorbidity: Results of Universal Testing of 1970 Residents.
    Tang O; Bigelow BF; Sheikh F; Peters M; Zenilman JM; Bennett R; Katz MJ
    J Am Med Dir Assoc; 2020 Dec; 21(12):1767-1773.e1. PubMed ID: 33153910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
    Harrison SL; Fazio-Eynullayeva E; Lane DA; Underhill P; Lip GYH
    PLoS Med; 2020 Sep; 17(9):e1003321. PubMed ID: 32911500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age/BMI is a Stronger Predictor of Death in COVID-19 Patients than Age Alone: A Pilot Study.
    Al Balwi W; Al Turki M; Memish ZA; Fakhoury HMA; Al Balwi M; Hajeer AH
    J Epidemiol Glob Health; 2022 Dec; 12(4):548-551. PubMed ID: 36355277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 28th day of the disease course: a retrospective cohort study in Bangladesh.
    Islam MZ; Riaz BK; Islam ANMS; Khanam F; Akhter J; Choudhury R; Farhana N; Jahan NA; Uddin MJ; Efa SS
    Epidemiol Infect; 2020 Oct; 148():e263. PubMed ID: 33115547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.